← All sarcoma trials
Recruiting nowAges 3 Years to 25 Years

Biomarkers of Resiliency In Childhood Cancer Surgery

Sponsor: Mayo Clinic · NCT06674811 on ClinicalTrials.gov ↗

Conditions studied

Pediatric CancerNeuroblastomaSarcomaWilms Tumor and Other Childhood Kidney TumorsChildhood Soft Tissue SarcomaChildhood Bone SarcomaChildhood Malignant Intestinal NeoplasmChildhood Malignant Liver NeoplasmChildhood Malignant Lung NeoplasmChildhood Malignant Ovarian NeoplasmChildhood Malignant Pleural NeoplasmChildhood Neuroblastic TumorChildhood Sarcoma

What it tests

  • Wearing Smartwatchother
  • Patient Report Outcomesother
  • Blood Drawother
  • Clinical Data Reviewother

Where it's running1 site

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* 3-25 years old at enrollment
* With solid tumors of the chest, abdomen, and extremities including neuroblastic tumors, sarcoma including soft tissue and bone, kidney tumors, liver tumors, ovarian tumors, lung and pleural-based tumors, and intestinal tumors

-OR-

* Guardian or primary caregiver of patient 3-25 years old with one of the aforementioned tumors.

Exclusion Criteria:

* Patients who are known to be pregnant or prisoners.

Updated 2026-01-26 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.